Laboratory research record on GLP-1S [PMID: 35135753] PubMed laboratory record discussing GLP-1S in a research context
The area under the pH measurements-time curve from 0 to 3 h after the 9 th daily dose of oral semaglutide divided by the actual time interval during which pH measurements were being taken (AUC 03h,pH,Day9 /time) was calculated using the linear trapezoidal method
L-ornithine L-aspartate, L-glutathione reduced, shell (hydroxypropyl methyl cellulose), N-acetyl-L-cysteine, milk thistle (Silybum marianum) seed extract, inulin 2 capsules, after a meal
A GLP-1/GIP dual receptor agonist DA4-JC effectively attenuates cognitive impairment and pathology in the APP/PS1/Tau model of alzheimers disease
The active ingredient in Mounjaro, tirzepatide, appears to be more effective than semaglutide, which is the active drug in Ozempic and Wegovy
By the end of week 5, my basal was down 30% and my mealtime bolus was down by 50%. Looking ahead: Whats next for GLP-1s in type 1 diabetes